Steep Hill Releases Open Letter to Washington State Cannabis Community
Testing lab issues a call to action to prevent contaminated cannabis from entering consumer supply chain
BERKELEY, Calif., March 30, 2016 /PRNewswire/ — Today, Steep Hill released an Open Letter to the Washington State Cannabis Community encouraging a call to action to prevent contaminated cannabis from entering the patient and consumer supply chain.
In issuing the Open Letter, Steep Hill CEO Jmîchaeĺe Keller said, “In a recent third party audit of certified i502 laboratories inWashington State, cannabis contaminated with pesticides and microbiological organisms like E. coli are being passed by certain disreputable labs, which means unsafe products are getting onto shelves. This is unacceptable when technology and the proper science are in place to insure safety to prevent health risk to consumers and patients.”
Steep Hill stands with other leading labs in the industry, like Trace Analytics, who apply scientific best practices to put public health first. “Together we are here to uphold standards of quality in this industry for consumer protection, and we cannot succeed if other laboratories cheat the system,” said Keller.
Keller emphasized, “We will continue to work with State regulators to clamp down on labs who focus more on profits than safety, and we ask you to raise your voice with us as we demand enforcement of uniform testing standards for consumer protection.”
For more information on this important call to action, the Open Letter will run in key Washington State markets today or can be found at http://landing.steephill.com/washington-safety.
ABOUT STEEP HILL
Founded in California in 2008, Steep Hill Labs, Inc. is a science and technology firm that has become the industry leader in cannabis testing and analytics. With labs in five states now, more to launch in 2016, and a joint venture with the University of Technology in Jamaica, Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California—the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™ and GenKit™. Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing, mapping and trademark protection services for the industry as well.
Contact: Cathie Bennett Warner